Ming Lim With Team Highlights The Importance of Identifying NSHA Patients
Ming Lim, Clinical Associate Professor at University of Utah, shared on LinkedIn:
“Using the My Life Our Future Research Repository, we analyzed the largest known cohort of individuals with non-severe hemophilia A (NSHA) who developed inhibitors (n=142). We identified 70 distinct F8 gene variants where inhibitor development occurred in a multiethnic cohort. These findings highlight the importance of identifying NSHA patients at-risk for inhibitors to improve clinical management and outcomes.
This study took years in the making, and would not have been possible without the support of the HTRS Mentored Research Award, Nigel Key, Jill Johnsen, Kristy Lee, American Thrombosis and Hemostasis Network (ATHN) and Tammuella Chrisentery-Singleton, and the My Life Our Future Research Repository.”
Title: F8 Variants and Inhibitor Development in a Multiethnic Cohort of Nonsevere Haemophilia A
Authors: Ming Y. Lim, Kristy Lee, Jill M. Johnsen, Nigel S. Key
Read full article here.
Stay updated about latest Haemophilia A news with Hemostasis Today.
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy
-
Dec 14, 2025, 16:06Dr Abdul Mannan: What’s Your Approach to Diagnosing Iron Deficiency in Tricky Cases?